AbbVie Strengthens Blood Cancer Leadership with New EHA 2026 Clinical Findings
NORTH CHICAGO, Illinois, USA – June 8, 2026 AbbVie has announced the presentation of new clinical and translational research...
fibrosis
Advertisement
Vasa Therapeutics Presents New VS-041 Data for HFpEF at ECM2026
ENCINITAS, California, USA & WROCLAW, Poland – June 8, 2026 Vasa Therapeutics, a clinical-stage biotechnology company focused on therapies...
MediciNova Completes Phase 2 MN-001 Trial in NAFLD
LA JOLLA, Calif., May 26, 2026 MediciNova announced the completion of the Last Patient Last Visit (LPLV) in its...
Innovent Highlights Bispecific Antibody Pipeline at ATS and ARVO 2026
SAN FRANCISCO and SUZHOU, China, May 18, 2026 Innovent Biologics presented new clinical and preclinical data from its next-generation...
Advertisement
